Attix Pharmaceuticals Inc
⚠️ High Risk
FEI: 3011918846 • Toronto, Ontario • CANADA
FEI Number
3011918846
Location
Toronto, Ontario
Country
CANADAAddress
481 University Ave Unit 502, , Toronto, Ontario, Canada
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 2/21/2018 | 66YIY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 3280FRNMFGREG | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 66YDY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 3280FRNMFGREG | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 56FCS99PEPTIDE N.E.C. | 3280FRNMFGREG | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 3280FRNMFGREG | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 56FCS99PEPTIDE N.E.C. | Division of Northeast Imports (DNEI) | |
| 2/21/2018 | 64RCY17ANASTROZOLE (HORMONE) | Division of Northeast Imports (DNEI) | |
| 2/21/2018 | 56FYT99PEPTIDE N.E.C. | Division of Northeast Imports (DNEI) | |
| 2/21/2018 | 56FCS99PEPTIDE N.E.C. | Division of Northeast Imports (DNEI) | |
| 2/21/2018 | 65PAR02SILDENAFIL CITRATE (REGULATOR) | Division of Northeast Imports (DNEI) | |
| 2/21/2018 | 61XOR29PYRILAMINE MALEATE (ANTI-HISTAMINIC) | Division of Northeast Imports (DNEI) | |
| 2/21/2018 | 66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 118NOT LISTED | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 65PCT02SILDENAFIL CITRATE (REGULATOR) | 118NOT LISTED | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 64RLT99HORMONE N.E.C. | 118NOT LISTED | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 66YIY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | Division of Northeast Imports (DNEI) | |
| 2/21/2018 | 56FYT99PEPTIDE N.E.C. | Division of Northeast Imports (DNEI) | |
| 2/21/2018 | 56FCS99PEPTIDE N.E.C. | Division of Northeast Imports (DNEI) | |
| 2/21/2018 | 56FYT99PEPTIDE N.E.C. | Division of Northeast Imports (DNEI) | |
| 2/21/2018 | 60SCT21CISAPRIDE (ANTACID) | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 64GCT19ETHINYL ESTRADIOL (ESTROGEN) | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 64UCT08DUTASTERIDE | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 64UCT08DUTASTERIDE | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 64UCT08DUTASTERIDE | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 62ICT13CHLORAMBUCIL (ANTI-NEOPLASTIC) | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 62VCT25FAMCICLOVIR (ANTI-VIRAL) | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 62VCT25FAMCICLOVIR (ANTI-VIRAL) | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 66YIY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 66YIY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 66YIY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 66YCT99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 61HAR05ZINC PYRITHIONE (ANTI-BACTERIAL) | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 54ADR05VITAMIN B12 (CYANOCOBALAMIN) | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 61LAR38CLOPIDOGREL BISULFATE (ANTI-COAGULANT) | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 60ZOR99ANTIPARASITIC, N.E.C. | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 60ZOR99ANTIPARASITIC, N.E.C. | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 56OYT05ENROFLOXACIN (FLUOROQUINOLONE) | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
| 2/21/2018 | 56OYT05ENROFLOXACIN (FLUOROQUINOLONE) | 16DIRECTIONS | Division of Northeast Imports (DNEI) |
Frequently Asked Questions
What is Attix Pharmaceuticals Inc's FDA import refusal history?
Attix Pharmaceuticals Inc (FEI: 3011918846) has 36 FDA import refusal record(s) in our database, spanning from 2/21/2018 to 2/21/2018.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Attix Pharmaceuticals Inc's FEI number is 3011918846.
What types of violations has Attix Pharmaceuticals Inc received?
Attix Pharmaceuticals Inc has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Attix Pharmaceuticals Inc come from?
All FDA import refusal data for Attix Pharmaceuticals Inc is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.